OrbitalRX

OrbitalRX

Private
Winston-Salem, North CarolinaHealthcare & Life Scienceshttps://orbitalrx.com

Last Round

Series A

May 26, 2023

Total Funding Raised

$5.11M

Momentum Score

50 /100

Company Overview

OrbitalRX is a healthcare technology company that provides a drug shortage management software designed to assist hospital pharmacy teams in improving medication shortages.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Vertical SaaS, Healthcare Analytics, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

drug shortage managementhospital pharmacy softwarepharmacy supply chainpharmacy workflow automationdrug inventory managementpharmacy techsupply chain visibilitypharmacy procurement softwarehealthcare SaaSpharmacy analyticsMicromedex integrationclinical supply chainpharmacy decision support

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OrbitalRX Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OrbitalRX Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series AMay 26, 2023
SeedMar 1, 2021
SeedAug 14, 2019
SeedOct 5, 2018

Key People

Founding team and executive leadership

Nate Peaty

Founder Chief Product Officer

Founding Team

Jason Gasper

Chief Executive Officer And Board Member

Executive Team

Mayank Thanawala

CTO (Fractional)

Executive Team

OrbitalRX Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors increased 40% MoM, reaching 1.4K.

OrbitalRX Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OrbitalRX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OrbitalRX's valuation, stock price, and market status.

Firmographic Details

HeadquartersWinston-Salem, North Carolina
Employee Range12
Year Founded2017
Last FundingMay 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.